Virtual Reality-Based Upper Limb Rehabilitation in Hemiplegia
Turkey (Türkiye)40 participantsStarted 2023-01-23
Plain-language summary
This study aims to evaluate the effectiveness of Leap Motion-supported virtual reality therapy, applied in addition to traditional rehabilitation programs, in individuals who develop hemiplegia after a cerebrovascular accident. The study will examine the effects of this additional therapy on upper extremity functions, activities of daily living, and participation levels.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients must be above eighteen years of age
* Have had a first-time stroke
* Be within twelve months of stroke
* Have a Brunnstrom score of four or more for the upper extremity
* Be cognitively adequate (scoring ≥23 on the mini-mental test scale)
Exclusion Criteria:
* Being in the unstable phase of the disease
* Visual and/or auditory impairments
* Unilateral spatial neglect (hemineglect)
* Modified Ashworth Scale score of ≥3 in the affected upper limb
* Had a history of botulinum toxin A (Botox) injection in the affected upper limb within the previous six months
* Other systemic neuromuscular disorders (exc; Alzheimer Disease, Parkinson Disease, Multipl Sclerosis...)
* Have cerebellar involvement characterised by dysmetria, dysdiadochokinesia or ataxia
* Have a prior orthopaedic or neuromuscular injuries affecting both upper limbs
* Have impaired static sitting balance
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fugl-Meyer assessment for upper extremity
Timeframe: baseline (T0), at the end of treatment (T1), one month after treatment completion (T2), and three months after treatment completion (T3)
Trial details
NCT IDNCT07378085
SponsorGaziosmanpasa Research and Education Hospital